2013 promises to be as tumultuous as 2012, as the industry looks to contend with the political ping-pong ball that is healthcare. Faced with myriad internal and external pressures, life-sciences companies of all types and sizes will need to address a growing stakeholder base that is better informed and better armed to make far-reaching decisions that could potentially impact the industry for years to come. They will also have to streamline how they develop and commercialize their products and improve the value provided to the overall healthcare system, while enhancing operating efficiencies.
Jade Cusick, president of U.S. marketing insights at Kantar Health, says the growing oversight and power of regulatory and payer bodies and their increased focus on not only value but affordability, along with an increasingly more informed and engaged consumer, will continue to represent the most significant forces acting on the…
Biotech In Action
A Shift in the Model